Cartesian Therapeutics(RNAC)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RNAC Cartesian Therapeutics

交易中 12-05 10:25:28 EST

6.80

-0.10

-1.45%

最高7.06	最低6.80	成交量1.66万
今开6.93	昨收6.90	日振幅3.69%
总市值1.77亿	流通市值6,386万	总股本2,600万
成交额11.52万	换手率0.18%	流通股本939.03万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RNAC","market":"US","secType":"STK","nameCN":"Cartesian Therapeutics","latestPrice":6.8001,"timestamp":1764948318175,"preClose":6.9,"halted":0,"volume":16585,"delay":0,"floatShares":9390341,"shares":26003606,"eps":-1.874951,"marketStatus":"交易中","change":-0.0999,"latestTime":"12-05 10:25:28 EST","open":6.93,"high":7.055,"low":6.8001,"amount":115209.92489000001,"amplitude":0.036942,"askPrice":6.96,"askSize":100,"bidPrice":6.81,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.874951,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1764968400000},"marketStatusCode":2,"adr":0,"listingDate":1466568000000,"exchange":"NASDAQ","adjPreClose":6.9,"postHourTrading":{"tag":"盘后","latestPrice":6.9,"preClose":6.9,"latestTime":"16:21 EST","volume":51121,"amount":352734.9,"timestamp":1764883318097},"volumeRatio":0.487064,"impliedVol":1.1029,"impliedVolPercentile":0.8148},"requestUrl":"/m/hq/s/RNAC","defaultTab":"news","newsList":[{"id":"1104267612","title":"Cartesian Therapeutics宣布Descartes-08针对SLE患者的二期试验显示强效信号，并扩展临床开发至肌炎","url":"https://stock-news.laohu8.com/highlight/detail?id=1104267612","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104267612?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:43","pubTimestamp":1763574227,"startTime":"0","endTime":"0","summary":"11月13日 - Cartesian Therapeutics Inc：*Cartesian Therapeutics宣布Descartes-08针对SLE患者的二期试验显示强效信号，并扩展临床开发至肌炎*Cartesian - 在二期开放标签试验中，SLE患者使用Descartes-08后观察到100%的LLDAS反应率，且在第3个月的跟进中得以确认*Cartesian Therapeutics","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC","BK4139"],"gpt_icon":0},{"id":"2583848657","title":"Cartesian Therapeutics, Inc.2025财年第三财季实现净利润-35.90百万美元，同比减少48.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583848657","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583848657?lang=zh_cn&edition=full","pubTime":"2025-11-16 00:00","pubTimestamp":1763222435,"startTime":"0","endTime":"0","summary":"11月16日，Cartesian Therapeutics, Inc.公布财报，公告显示公司2025财年第三财季净利润为-35.90百万美元，同比减少48.47%；其中营业收入为452000.00美元，同比增加16.80%，每股基本收益为-1.38美元。机构评级：截至2025年11月16日，当前有7家机构对Cartesian Therapeutics, Inc.目标价做出预测，其中目标均价为36.71美元，其中最低目标价为16.00美元，最高目标价为44.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116000117a4a3df11&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251116000117a4a3df11&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAC","LENZ"],"gpt_icon":0},{"id":"1106843970","title":"Cartesian：肌炎无缝适应性临床试验设计为预计在2026年上半年启动的单一关键试验提供潜在机会","url":"https://stock-news.laohu8.com/highlight/detail?id=1106843970","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106843970?lang=zh_cn&edition=full","pubTime":"2025-11-14 05:08","pubTimestamp":1763068105,"startTime":"0","endTime":"0","summary":"Cartesian：肌炎无缝适应性临床试验设计为预计在2026年上半年启动的单一关键试验提供潜在机会","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC","BK4139"],"gpt_icon":0},{"id":"1162703750","title":"Cartesian - 在第2期开放标签试验中，接受Descartes-08治疗的系统性红斑狼疮患者在第3个月的随访中观察到100%的Lldas反应率","url":"https://stock-news.laohu8.com/highlight/detail?id=1162703750","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162703750?lang=zh_cn&edition=full","pubTime":"2025-11-14 05:06","pubTimestamp":1763067981,"startTime":"0","endTime":"0","summary":"Cartesian - 在第2期开放标签试验中，接受Descartes-08治疗的系统性红斑狼疮患者在第3个月的随访中观察到100%的Lldas反应率","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAC"],"gpt_icon":0},{"id":"1154783186","title":"Cartesian Therapeutics在SLE患者的Descartes-08 II期试验中显示出强效信号，并扩大临床开发至肌炎领域","url":"https://stock-news.laohu8.com/highlight/detail?id=1154783186","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154783186?lang=zh_cn&edition=full","pubTime":"2025-11-14 05:06","pubTimestamp":1763067979,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics在SLE患者的Descartes-08 II期试验中显示出强效信号，并扩大临床开发至肌炎领域","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC","BK4139"],"gpt_icon":0},{"id":"1177621336","title":"Cartesian Therapeutics报告截至9月30日现金、现金等价物及受限现金约为1.451亿美元，预计可支撑其计划运营至2027年中期","url":"https://stock-news.laohu8.com/highlight/detail?id=1177621336","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177621336?lang=zh_cn&edition=full","pubTime":"2025-11-06 20:23","pubTimestamp":1762431815,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics报告截至9月30日现金、现金等价物及受限现金约为1.451亿美元，预计可支撑其计划运营至2027年中期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC","BK4139"],"gpt_icon":0},{"id":"1145559967","title":"Cartesian Therapeutics宣布Carsten Brunn博士出任公司董事会主席","url":"https://stock-news.laohu8.com/highlight/detail?id=1145559967","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145559967?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:03","pubTimestamp":1761822201,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics宣布Carsten Brunn博士被任命为公司董事会主席","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RNAC"],"gpt_icon":0},{"id":"1120742570","title":"Cartesian Therapeutics：向现任首席科学官Christopher Jewell发出无因解雇通知","url":"https://stock-news.laohu8.com/highlight/detail?id=1120742570","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120742570?lang=zh_cn&edition=full","pubTime":"2025-10-21 19:04","pubTimestamp":1761044648,"startTime":"0","endTime":"0","summary":"Cartesian Therapeutics：向现任首席科学官Christopher Jewell发出无因解雇通知","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNAC","BK4139"],"gpt_icon":0},{"id":"2516668789","title":"Cartesian Therapeutics, Inc.盘中异动 快速跳水5.04%报17.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516668789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516668789?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:24","pubTimestamp":1741033455,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时24分，Cartesian Therapeutics, Inc.股票出现波动，股价急速下挫5.04%。截至发稿，该股报17.89美元/股，成交量12.1887万股，换手率0.47%，振幅3.42%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Celularity Inc C/Wts 16/07/2026 涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4605.74%、213.48%、183.42%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042415a25da197&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042415a25da197&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAC","BK4139","LENZ"],"gpt_icon":0},{"id":"2516309937","title":"Cartesian Therapeutics, Inc.盘中异动 临近收盘大幅拉升5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516309937","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516309937?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:32","pubTimestamp":1740774761,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时32分，Cartesian Therapeutics, Inc.股票出现异动，股价急速拉升5.19%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Enveric Biosciences, Inc.、Bioxcel Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3274.50%、601.95%、399.87%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为57.80%、49.90%、48.19%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301043241a25852d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301043241a25852d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAC","BK4139","LENZ"],"gpt_icon":0},{"id":"2514862712","title":"Cartesian Therapeutics, Inc.盘中异动 临近收盘股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514862712","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514862712?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:37","pubTimestamp":1740602222,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时37分，Cartesian Therapeutics, Inc.股票出现异动，股价大幅下跌5.09%。截至发稿，该股报18.10美元/股，成交量5.3639万股，换手率0.21%，振幅6.48%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。其相关个股中，Enveric Biosciences, Inc.、Renovaro Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Enveric Biosciences, Inc.、Aeon Biopharma, Inc.、Organovo Holdings, Inc.较为活跃，换手率分别为6870.06%、346.64%、265.50%，振幅较大的相关个股有Enveric Biosciences, Inc.、Renovaro Inc.、Immatics N V C/Wts 01/07/2025 ，振幅分别为194.07%、81.11%、70.39%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270437029893ec41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502270437029893ec41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNAC","LENZ","BK4139"],"gpt_icon":0},{"id":"2509728627","title":"Cartesian Therapeutics, Inc.盘中异动 急速下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509728627","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509728627?lang=zh_cn&edition=full","pubTime":"2025-02-07 23:48","pubTimestamp":1738943314,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日23时48分，Cartesian Therapeutics, Inc.股票出现波动，股价快速下跌5.16%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Conduit Pharmaceuticals Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃，换手率分别为4282.50%、149.12%、91.27%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.，振幅分别为130.43%、60.00%、53.38%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207234834a23d34d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207234834a23d34d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RNAC"],"gpt_icon":0},{"id":"2509349509","title":"Cartesian Therapeutics, Inc.盘中异动 下午盘股价大跌5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509349509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509349509?lang=zh_cn&edition=full","pubTime":"2025-02-05 03:47","pubTimestamp":1738698456,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日03时47分，Cartesian Therapeutics, Inc.股票出现波动，股价急速下跌5.44%。截至发稿，该股报18.81美元/股，成交量1.1114万股，换手率0.04%，振幅4.37%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.66%。其相关个股中，Cingulate Inc C/Wts 10/12/2026 、Estrella Immunopharma Inc C/Wts 29/09/2028、Mink Therapeutics, Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为1913.83%、984.88%、585.70%，振幅较大的相关个股有Azitra Inc、Omega Therapeutics, Inc.、Mink Therapeutics, Inc.，振幅分别为123.99%、59.42%、58.02%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205034736a23962a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205034736a23962a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","RNAC"],"gpt_icon":0},{"id":"2507658231","title":"Cartesian Therapeutics, Inc.盘中异动 早盘股价大跌6.15%报18.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507658231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507658231?lang=zh_cn&edition=full","pubTime":"2025-01-30 00:15","pubTimestamp":1738167342,"startTime":"0","endTime":"0","summary":"北京时间2025年01月30日00时15分，Cartesian Therapeutics, Inc.股票出现异动，股价快速跳水6.15%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Silexion Therapeutics Corp、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Silexion Therapeutics Corp、60 Degrees Pharmaceuticals, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为4630.39%、2164.24%、740.32%，振幅较大的相关个股有Ocean Biomedical Inc C/Wts 14/02/2028 、Protagenic Therapeutics Inc C/Wts 29/04/2026 、Ocean Biomedical, Inc.，振幅分别为185.36%、95.00%、93.15%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013000154298761670&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013000154298761670&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RNAC","BK4139"],"gpt_icon":0},{"id":"2505067727","title":"Cartesian Therapeutics, Inc.盘中异动 早盘快速下跌6.57%报18.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505067727","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505067727?lang=zh_cn&edition=full","pubTime":"2025-01-23 00:05","pubTimestamp":1737561924,"startTime":"0","endTime":"0","summary":"北京时间2025年01月23日00时05分，Cartesian Therapeutics, Inc.股票出现异动，股价快速下跌6.57%。截至发稿，该股报18.55美元/股，成交量1.8574万股，换手率0.07%，振幅3.48%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Immunoprecise Antibodies Ltd.、Dermata Therapeutics Inc C/Wts 、Nutriband Inc C/Wts 涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为884.68%、182.84%、70.99%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Nutriband Inc C/Wts 、Immunoprecise Antibodies Ltd.，振幅分别为53.51%、50.39%、47.48%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123000524abb4b9ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250123000524abb4b9ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RNAC"],"gpt_icon":0},{"id":"2503674850","title":"Cartesian Therapeutics, Inc.盘中异动 下午盘大幅拉升5.94%报19.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503674850","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503674850?lang=zh_cn&edition=full","pubTime":"2025-01-16 04:14","pubTimestamp":1736972091,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日04时14分，Cartesian Therapeutics, Inc.股票出现波动，股价大幅拉升5.94%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.46%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Aditxt, Inc.、Windtree Therapeutics, Inc.、Phio Pharmaceuticals Corp.较为活跃，换手率分别为1095.07%、242.06%、215.18%，振幅较大的相关个股有Os Therapies Incorporated、Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 ，振幅分别为70.43%、68.03%、68.00%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116041451a2234bfb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116041451a2234bfb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RNAC","BK4139"],"gpt_icon":0},{"id":"2503581013","title":"Cartesian Therapeutics, Inc.盘中异动 股价大涨5.37%报17.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503581013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503581013?lang=zh_cn&edition=full","pubTime":"2025-01-13 23:48","pubTimestamp":1736783302,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日23时48分，Cartesian Therapeutics, Inc.股票出现波动，股价大幅拉升5.37%。截至发稿，该股报17.75美元/股，成交量3.7858万股，换手率0.15%，振幅7.24%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为10011.37%、5565.32%、419.86%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为318.93%、216.61%、124.54%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132348229864e3d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501132348229864e3d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RNAC","BK4139"],"gpt_icon":0},{"id":"2501987572","title":"Cartesian Therapeutics, Inc.盘中异动 下午盘股价大涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501987572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501987572?lang=zh_cn&edition=full","pubTime":"2025-01-07 02:24","pubTimestamp":1736187879,"startTime":"0","endTime":"0","summary":"北京时间2025年01月07日02时24分，Cartesian Therapeutics, Inc.股票出现异动，股价急速拉升5.40%。截至发稿，该股报17.76美元/股，成交量11.3862万股，换手率0.45%，振幅7.42%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。其相关个股中，Scisparc Ltd.、Unity Biotechnology, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Scisparc Ltd.、Cns Pharmaceuticals, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为1659.99%、378.36%、166.85%，振幅较大的相关个股有Scisparc Ltd.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为176.15%、106.67%、92.16%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107022439aba0b98b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250107022439aba0b98b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RNAC","BK4139"],"gpt_icon":0},{"id":"2500648244","title":"Cartesian Therapeutics, Inc.盘中异动 股价大跌5.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2500648244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500648244?lang=zh_cn&edition=full","pubTime":"2025-01-01 01:36","pubTimestamp":1735666566,"startTime":"0","endTime":"0","summary":"北京时间2025年01月01日01时36分，Cartesian Therapeutics, Inc.股票出现波动，股价快速下挫5.98%。截至发稿，该股报17.64美元/股，成交量4.7817万股，换手率0.19%，振幅6.61%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，知临集团、Onconetix, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Onconetix, Inc.、知临集团、Eyenovia, Inc.较为活跃，换手率分别为2793.94%、1836.87%、319.66%，振幅较大的相关个股有Onconetix, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、知临集团，振幅分别为265.45%、248.39%、204.42%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101013606ab99a3e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250101013606ab99a3e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","RNAC","BK4139"],"gpt_icon":0},{"id":"2495550514","title":"Cartesian Therapeutics, Inc.盘中异动 下午盘股价大跌5.61%报18.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2495550514","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495550514?lang=zh_cn&edition=full","pubTime":"2024-12-31 04:19","pubTimestamp":1735589979,"startTime":"0","endTime":"0","summary":"北京时间2024年12月31日04时19分，Cartesian Therapeutics, Inc.股票出现波动，股价大幅下挫5.61%。截至发稿，该股报18.68美元/股，成交量5.0189万股，换手率0.20%，振幅3.36%。Cartesian Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.23%。Cartesian Therapeutics, Inc.公司简介：Cartesian Therapeutics Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231041939985569ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231041939985569ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","RNAC"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.selectabio.com","stockEarnings":[{"period":"1week","weight":-0.0921},{"period":"1month","weight":-0.1051},{"period":"3month","weight":-0.3515},{"period":"6month","weight":-0.3747},{"period":"1year","weight":-0.6864},{"period":"ytd","weight":-0.6147}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.0136},{"period":"3month","weight":0.0574},{"period":"6month","weight":0.1423},{"period":"1year","weight":0.1263},{"period":"ytd","weight":0.1677}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cartesian Therapeutics, Inc.在特拉华州成立。该公司是一家临床阶段的公司，开创了治疗自身免疫性疾病的RNA细胞疗法。该公司的主要资产Descartes-08是一种潜在的first-in-class、RNA工程嵌合抗原受体T细胞疗法（rCAR-T），正处于全身性重症肌无力患者的2b期临床开发阶段，并计划在系统性红斑狼疮以及眼部自身免疫和血管性自身免疫篮子试验中开展额外的2期研究。Cartesian在马里兰州盖瑟斯堡经营一家全资拥有的最先进的cGMP生产设施。","yearOnYearQuotes":[{"month":1,"riseRate":0.555556,"avgChangeRate":0.069643},{"month":2,"riseRate":0.555556,"avgChangeRate":0.002515},{"month":3,"riseRate":0.444444,"avgChangeRate":-0.091249},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.088422},{"month":5,"riseRate":0.666667,"avgChangeRate":0.155539},{"month":6,"riseRate":0.444444,"avgChangeRate":0.054888},{"month":7,"riseRate":0.3,"avgChangeRate":-0.074772},{"month":8,"riseRate":0.7,"avgChangeRate":0.054751},{"month":9,"riseRate":0.5,"avgChangeRate":0.015696},{"month":10,"riseRate":0.5,"avgChangeRate":-0.020193},{"month":11,"riseRate":0.5,"avgChangeRate":-0.029903},{"month":12,"riseRate":0.2,"avgChangeRate":-0.111672}],"exchange":"NASDAQ","name":"Cartesian Therapeutics","nameEN":"Cartesian Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cartesian Therapeutics(RNAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cartesian Therapeutics(RNAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cartesian Therapeutics,RNAC,Cartesian Therapeutics股票,Cartesian Therapeutics股票老虎,Cartesian Therapeutics股票老虎国际,Cartesian Therapeutics行情,Cartesian Therapeutics股票行情,Cartesian Therapeutics股价,Cartesian Therapeutics股市,Cartesian Therapeutics股票价格,Cartesian Therapeutics股票交易,Cartesian Therapeutics股票购买,Cartesian Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cartesian Therapeutics(RNAC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cartesian Therapeutics(RNAC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}